Core Viewpoint - The announcement of share reduction plans by the major shareholders of Gongdong Medical indicates a potential liquidity event, with a total of up to 6,614,787 shares, or 3% of the total share capital, set to be sold within the next three months [1][2] Shareholder Reduction Plans - The controlling shareholder, Shi Huiyong, plans to reduce holdings by up to 4,409,858 shares, which is 2% of the total share capital, through block trading [1] - Taizhou Jincheng Investment Management Partnership intends to reduce holdings by up to 2,204,929 shares, or 1% of the total share capital, via centralized bidding [1] - Combined, the two shareholders will reduce a total of up to 6,614,787 shares, representing 3% of the total share capital [1] Financial Implications - Based on the closing price of 19.38 yuan on September 4, the total cashing out from the planned reductions is approximately 128,194,572.06 yuan [2] - As of the announcement date, Shi Huiyong holds 110,836,040 shares (50.27% of total shares), while Jincheng Investment holds 14,258,009 shares (6.47% of total shares) [2] Shareholding Structure - Shi Huiyong, Shi Yibei, and Jincheng Investment collectively hold 141,558,049 shares, accounting for 64.21% of the total share capital [2] - Jincheng Investment is an employee stock ownership platform, and Shi Huiyong will not participate in this reduction [2] Previous Reduction Activities - Shi Huiyong has previously reduced his holdings by 3,151,400 shares, cashing out approximately 80.36 million yuan [4] - Jincheng Investment has also reduced its holdings by 1,575,700 shares, with a total cashing out of about 43.56 million yuan [5][6] - The cumulative cashing out by both shareholders amounts to approximately 123.92 million yuan [6]

Key Points - Zhonghuan Hailu terminated the planning of the change of company control and resumed trading [1][2] - Shida Shenghua plans to establish a subsidiary with an investment of 25 million yuan to build a 53,000 tons/year calcium chloride project [1] - Southeast Network Frame won a bid for approximately 1.686 billion yuan for the Pujiang Street Five Villages joint planning and development project [1] - Roman Co. intends to acquire 39.2308% equity of Wutong Gaoxin for 196 million yuan [1] - Torch Electronics completed a share repurchase, having repurchased shares worth 49.9907 million yuan [1] - Jiangling Motors reported cumulative sales of 226,500 vehicles from January to August, a year-on-year increase of 5.67% [1] - Wen's Co. reported August sales revenue of 2.956 billion yuan for broilers and 4.825 billion yuan for live pigs [2] - Some directors and senior management of Shanghai Caishi plan to increase their holdings by no less than 6 million yuan [1] - Actual controller of Gongdong Medical, Shi Huiyong, plans to reduce holdings by no more than 4.4099 million shares through block trading [1] - Shida Shenghua's subsidiary establishment and investment in the calcium chloride project indicates growth in the chemical industry [1]

Group 1: Company Announcements - Heng Rui Medicine has received the clinical trial approval notice for HRS-4729 injection, a self-developed peptide drug targeting GLP-1R, GIPR, and GCGR receptors, with no similar products approved in the market [1] - Hubei Yihua has successfully launched its 200,000 tons/year caustic soda project, aimed at upgrading its chlor-alkali chemical industry and enhancing market competitiveness [2] - Ji Min Health announced that its shareholder, Shuangge Group, plans to reduce its stake by up to 3%, equating to a maximum of 15.75 million shares [3] - China Shipbuilding intends to absorb and merge with China Shipbuilding Industry Corporation through a share exchange, with the latter's A-shares set to be delisted on September 5, 2025 [4] - Changfei Fiber reported that its shareholder, Changjiang Communication, plans to reduce its stake by up to 0.15%, totaling no more than 1.1 million shares [5] Group 2: Strategic Collaborations and Developments - Beijing Lier has signed a strategic cooperation agreement with SenseTime and Xiwang Technology to explore AI computing power collaboration and related applications [6] - Junsheng Electronics is collaborating with leading clients like Zhiyuan Robotics, having achieved bulk supply of customized main control boards and various sensors [7][8] - Guoxin Technology has successfully tested a new generation of high-performance chips for automotive electronic BLDC motor control, aimed at addressing the MCU chip shortage in the automotive sector [9] Group 3: Other Corporate Actions - Guoguang Chain's actual controller plans to reduce their stake by up to 2.99%, totaling a maximum of 12.506 million shares [10] - Zhonghuan Hailu has terminated its control change plan, with its stock set to resume trading on September 5, 2025 [11] - Various companies have reported significant project wins, including Ningbo Construction winning contracts worth 1.117 billion yuan [12]

Core Points - Gongdong Medical announced that as of the disclosure date, the controlling shareholder and actual controller, Shi Huiyong, holds 110,836,040 shares, accounting for 50.27% of the total share capital [2] - Taizhou Jinch Investment Management Partnership holds 14,258,009 shares, representing 6.47% of the total share capital [2] - Shi Huiyong plans to reduce his holdings by no more than 4,409,858 shares through block trading within three months after the disclosure date, with a limit of 2% of the total share capital within any consecutive 90 days [2] - Jinch Investment intends to reduce its holdings by no more than 2,204,929 shares through centralized bidding, which is also limited to 1% of the total share capital [2]

Group 1 - Shanghai Laishi's executives plan to collectively increase their holdings in the company by no less than 6 million yuan [1] - Noli Co., Ltd.'s actual controller and its concerted parties plan to reduce their holdings by no more than 3.11% [1] - Gongdong Medical's actual controller and concerted parties plan to reduce their holdings by no more than 3% [1] Group 2 - Jimin Health's actual controller's concerted party plans to reduce their holdings by no more than 3% [1] - Guoguang Chain's actual controller plans to reduce their holdings by no more than 2.99% [1] - Jiahe Meikang's Hongyun Jiukang plans to reduce their holdings by no more than 1% [1] Group 3 - Bolong Technology's supervisory board chairman plans to reduce their holdings by no more than 0.75% [1] - Changfei Optical Fiber's Yangtze Communication plans to reduce their holdings by no more than 0.15% [1] - Guoci Materials' shareholder Wang Hong plans to reduce their holdings by no more than 3 million shares [1]

Core Viewpoint - The major shareholder and actual controller of Zhejiang Gongdong Medical Instrument Co., Ltd., Shi Huiyong, plans to reduce his shareholding through block trading and centralized bidding methods, indicating a personal funding need [1][3]. Group 1: Shareholder Information - Shi Huiyong holds 110,836,040 shares, representing 50.27% of the company, while Taizhou Jinch Investment Management Partnership holds 14,258,009 shares, accounting for 6.47% [2]. - The total shareholding of Shi Huiyong and his family member, Shi Yibei, along with Jinch Investment, amounts to 141,558,049 shares, which is 64.21% of the total shares [2]. Group 2: Reduction Plan Details - Shi Huiyong intends to reduce his holdings by up to 4,409,858 shares, not exceeding 2% of the total shares, through block trading from September 26, 2025, to December 24, 2025 [3]. - Taizhou Jinch Investment plans to reduce its holdings by up to 2,204,929 shares, not exceeding 1% of the total shares, through centralized bidding during the same period [3]. - The reduction is motivated by personal funding needs for both Shi Huiyong and Taizhou Jinch Investment [3]. Group 3: Compliance and Commitments - The reduction plan complies with relevant laws and regulations, including the Company Law and Securities Law of the People's Republic of China [6]. - The company will adhere to disclosure obligations and will not alter commitments made regarding shareholding during the lock-up period [4][5].

浙江拱东医疗器械股份有限公司 股东减持股份计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 证券代码：605369 证券简称：拱东医疗 公告编号：2025-029 重要内容提示： 大股东及董监高持股的基本情况 截至本公告披露日，公司控股股东、实际控制人施慧勇持有公司股份 110,836,040 股，占公司总股本的 50.27%。台州金驰投资管理合伙企业（有限合 伙）（以下简称"金驰投资"）持有浙江拱东医疗器械股份有限公司（以下简称"公 司"、"拱东医疗"）股份 14,258,009 股，占公司总股本的 6.47%。 减持计划的主要内容 自本公告披露之日起 15 个交易日后的 3 个月内，公司控股股东、实际控制 人施慧勇拟通过大宗交易方式合计减持数量不超过 4,409,858 股，且在任意连续 90 日内，减持股份的总数不超过公司总股本的 2%。金驰投资拟通过集中竞价交 易方式合计减持数量不超过 2,204,929 股，即不超过公司总股本的 1%； 在减持计划实施期间，公司若发生派发红利、送红股、转增股本、增发 ...

Group 1 - The core point of the article is that Gongdong Medical (605369.SH) announced plans for share reduction by its controlling shareholder and actual controller, Shi Huiyong, through block trading and by Jinchi Investment through centralized bidding [1] Group 2 - Shi Huiyong intends to reduce holdings by no more than 4.4099 million shares within three months after the announcement, which represents up to 2% of the company's total share capital [1] - Jinchi Investment plans to reduce holdings by no more than 2.2049 million shares, equivalent to up to 1% of the company's total share capital [1]

Core Viewpoint - The company announced a share reduction plan by its controlling shareholder and significant stakeholders due to personal funding needs [1] Share Reduction Details - The controlling shareholder, Shi Huiyong, plans to reduce holdings by up to 4.4099 million shares, representing no more than 2% of the total share capital, through block trading from September 26, 2025, to December 24, 2025 [1] - Taizhou Jinch Investment Management Partnership intends to reduce holdings by up to 2.2049 million shares, also representing no more than 1% of the total share capital, through centralized bidding during the same period [1] - The implementation of this reduction plan carries uncertainty [1]

Core Points - The company Gongdong Medical (605369.SH) announced that its controlling shareholder and actual controller, Shi Huiyong, plans to reduce his holdings by a total of no more than 4.4099 million shares through block trading within three months after the announcement, which represents up to 2% of the company's total share capital [1] - Additionally, Jincheng Investment intends to reduce its holdings by no more than 2.2049 million shares through centralized bidding, also representing up to 1% of the company's total share capital [1]